The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.

@article{Rmillard2005TheEO,
  title={The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.},
  author={Sophie R{\'e}millard and Emmanuelle Pourcher and Henri Cohen},
  journal={Schizophrenia research},
  year={2005},
  volume={80 1},
  pages={99-106}
}
Cognitive dysfunctions (as in memory, attention and executive function) have been recognized as fundamental features of schizophrenia. Executive dysfunction is a major obstacle to functional outcome, community functioning and rehabilitation success and it is crucial to assess the effects of so-called neuroleptic (NLP) medications in this domain of cognitive functioning. Risperidone, an atypical NLP, has been reported to improve executive function in schizophrenia (SZ), but there is controversy… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Hippocampal integrity and neurocognition in first-episode schizophrenia: a multidimensional study.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry • 2014

Long-term skill proceduralization in schizophrenia.

Journal of the International Neuropsychological Society : JINS • 2010
View 2 Excerpts

Cognitive impairment of executive function as a core symptom of schizophrenia.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry • 2009
View 1 Excerpt

Similar Papers

Loading similar papers…